Hematologists near Bronx, NY

Biography: Dr. Julie Fasano, MD is a Hematology Specialist who practices in New York, NY. She is 52 years old and has been practicing for 23 years. Dr. Julie Fasano, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Giving a listening ear to my patients is my most precious source of clinical information.

Care Philosophy: For detailed information about Dr. Sekhri and Advanced Care Oncology and Hematology Associates (ACOHA) please visit www.njacoha. com. The practice was founded with a mission of providing the highest level of quality cancer and hematology care in a personalized, integrative approach. We care for adults with a wide range of blood disorders and cancers and treat patients by encompassing a 360 degree integrated approach in a private setting. Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Hearn Cho, MD is a Hematology Specialist who practices in New York, NY. He is 59 years old and has been practicing for 29 years. Dr. Hearn Cho, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Adriana Malone, MD is a Hematology Specialist who practices in New York, NY. She is 52 years old and has been practicing for 25 years. Dr. Adriana Malone, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Rajwanth Veluswamy, MD is a Hematology Specialist who practices in New York, NY. He is 45 years old. Dr. Rajwanth Veluswamy, MD is affiliated with Mount Sinai Hospital, Mount Sinai Queens and Mount Sinai Morningside.

Biography: Dr. Krzysztof Misiukiewicz, MD is a Hematology Specialist who practices in New York, NY. He is 52 years old. Dr. Krzysztof Misiukiewicz, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Matko Kalac, MD is a Hematology Specialist who practices in New York, NY. He is 46 years old. Dr. Matko Kalac, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Matthew Galsky, MD is a Hematology Specialist who practices in New York, NY. He is 53 years old and has been practicing for 27 years. Dr. Matthew Galsky, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Yelena Ginzburg, MD is a Hematology Specialist who practices in New York, NY. She is 54 years old. Dr. Yelena Ginzburg, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Multidisciplinary, respectful care of patients with GU cancers

Care Philosophy: As an oncologist, I believe providing the best state of the art treatment available for our patients. Our team of cancer specialists will ensure you will receive the best possible care.

Biography: Dr. Lyndon Kim, MD is a Hematology Specialist who practices in New York, NY. He is 71 years old and has been practicing for 40 years. Dr. Lyndon Kim, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Marina Kremyanskaya, MD is a Hematology Specialist who practices in New York, NY. She is 49 years old. Dr. Marina Kremyanskaya, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Marshall Posner, MD is a Hematology Specialist who practices in New York, NY. He is 76 years old and has been practicing for 50 years. Dr. Marshall Posner, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Hanna Irie, MD is a Hematology Specialist who practices in New York, NY. She is 55 years old. Dr. Hanna Irie, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Keren Osman, MD is a Hematology Specialist who practices in New York, NY. She is 55 years old and has been practicing for 29 years. Dr. Keren Osman, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Howard Greenberg, MD is a Hematology Specialist who practices in Astoria, NY. He is 77 years old and has been practicing for 52 years. Dr. Howard Greenberg, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Biography: Jones Nauseef, M.D., Ph.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. His clinical emphasis is on Genitourinary (GU) cancers and Phase I clinical trials. His research is focused on genomics of advanced prostate cancers, including neuroendocrine prostate cancer, as well as health care disparities.Dr. Nauseef received his B.A. in Biology in 2006 from Swarthmore College, where he also participated in NCAA Track and Cross Country. In 2015, Dr. Nauseef earned his M.D. and Ph.D. in Molecular Physiology and Biophysics (Laboratory of Dr. Michael D. Henry) as part of the NIH-sponsored MedicalScientist Training Program (MSTP) at the Carver College of Medicine of theUniversity of Iowa. He continued his medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP), where he completed his Internship and Residency in Internal Medicine in 2018. He was honored to be the recipient of the David B. Skinner award at the conclusion of his residency. He remained at WCM/NYP for his Fellowship in Hematology and Medical Oncology, during which time he was awarded a 2020 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) and the 2021 Scott Wadler Fellows Clinical Research Award. During his Fellowship, Dr. Nauseef expanded his research focus to include the genomics of advanced prostate cancers and health care disparities in American men of African descent. He serves as co-investigator or collaborator on extramural grants for the latter project. Dr. Nauseef will continue these investigations as a member of the Englander Institute for Precision Medicine and inaffiliation with the New York Genome Center, with the primary goal of leveraging discoveries to develop clinical trials as part of the Phase I/Earlytherapeutics group at Weill Cornell's Meyer Cancer Center.

Care Philosophy: Today's research and treatment of lung cancer are at the cutting edge of science and technology. Enormous progress has been made in lung cancer treatment. Several targeted therapies and now immunotherapies have changed the way we treat the disease. Cancer patients and their families who come to the Lombardi Comprehensive Cancer Center will work closely with a team of dedicated and knowledgeable cancer specialists to determine the most appropriate treatment path for their specific cancer needs. My research is focused on advancing our understanding of lung cancer and thymic tumors and their responses to specific treatment, including how to harness the body's immune system to fight cancer. I keep my patients and their families front and center in my practice to help them understand the technology that may be available to them. My goal is to always work together with my patients, using science to overcome disease.

Biography: Dr. Barbara T. Ma, is an Assistant Professor of Medicine at Weill Cornell Medicine and an Assistant Attending Physician at New York Presbyterian Hospital. Dr. Ma graduated with B.S. in Biomedical Engineering and M.S. in Biotechnology from Johns Hopkins University. She received her medical degree from New York Medical College. She completed her internal medicine training at Georgetown University Hospital and fellowship in Hematology/Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medicine, where she also served as a chief fellow. Dr. Ma cares for patients with skin cancers, including melanoma. Her research focus is optimizing immunotherapy treatments for solid tumor patients with special interest on immunotherapy toxicities. She heads the Phase I unit and leads Cellular Therapy for Solid Tumors at Cornell. Dr. Ma is a recipient of the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award. She is a member of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), Golden Humanism Honor Society (GHHS), and Society for Immunotherapy and Translational Research in Cancer.

Biography: Dr. Paul Pagnini has served as a leader in community-based and academic radiation oncology for the past 20 years. Dr. Pagnini completed his residency training in Radiation Oncology at Tufts/New England Medical Center where he was chief resident in his final year. He was awarded the prestigious Research Fellowship Award from the American Society of Therapeutic Radiation Oncology, which enabled him to study the role of intensity modulated radiation therapy (IMRT) for the treatment of cancers of the central nervous system. He has served on the Faculty of the University of Southern California, Keck School of Medicine where he was the Radiation Oncology Residency Program Director. His most recent position was with the Cleveland Clinic Florida, where he served as Department Chair for the last five years. He has multiple peer reviewed publications in the areas of intensity modulated radiation therapy (IMRT), 3-D conformal radiation therapy, Cyberknife, and Gamma-Knife radiosurgery.

Biography: Emily Tonorezos, MD MPH is a Clinical Associate Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine/New York-Presbyterian Hospital. Dr. Tonorezos received her bachelor's degree from Dartmouth College in Hanover, New Hampshire and her M.D. from the University of Rochester School of Medicine and Dentistry in 2001. Following Residency in Internal Medicine, she spent one year as Chief Resident in Internal Medicine, both at Columbia University Medical Center. She subsequently completed a General Internal Medicine fellowship at Johns Hopkins Hospital and Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health. Dr. Tonorezos joined Weill Cornell from Memorial Sloan Kettering Cancer Center, where she served as Director of the Adult Long-Term Follow-Up Program for adult survivors of childhood and young adult cancers.

Biography: Dr. Jonah Shulman, MD is a Hematology Specialist who practices in New York, NY. He is 42 years old and has been practicing for 15 years. Dr. Jonah Shulman, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Bruce Culliney, MD is a Hematology Specialist who practices in New York, NY. He is 66 years old. Dr. Bruce Culliney, MD is affiliated with Mount Sinai Morningside.

Biography: Dr. Nikhil Uppal is an Assistant Professor of Clinical Medicine at Weill Cornell Medical College in the Division of Hematology and Medical Oncology. He is the Site Director for Hematology/Oncology at NewYork-Presbyterian Lower Manhattan Hospital. He has experience with clinical and translational research studies and a special interest in pancreatic malignancies and lymphomas. Dr. Uppal sees patients at both the Weill Cornell Upper East Side and Lower Manhattan Campuses, and is accepting new patients.Dr. Uppal completed his Internal Medicine Residency at the University of Rochester and his Hematology/Oncology fellowship at Strong Memorial University Hospital. Prior to joining Weill Cornell Medicine, Dr. Uppal worked for New York University Langone Arena Oncology. He is a member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).

Biography: Dr. Bobby Liaw, MD is a Hematology Specialist who practices in New York, NY. He is 42 years old and has been practicing for 16 years. Dr. Bobby Liaw, MD is affiliated with Mount Sinai Queens, Mount Sinai Hospital and Mount Sinai Brooklyn.

Biography: Dr. Nicholas Rohs, MD is a Hematology Specialist who practices in New York, NY. He is 44 years old and has been practicing for 14 years. Dr. Nicholas Rohs, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Theresa Shao, MD is a Hematology Specialist who practices in New York, NY. She is 47 years old and has been practicing for 21 years. Dr. Theresa Shao, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Peter Kozuch, MD is a Hematology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 31 years. Dr. Peter Kozuch, MD is affiliated with Mount Sinai Hospital, Mount Sinai Morningside and Mount Sinai Queens.

Biography: Dr. Anupama Goel, MD is a Hematology Specialist who practices in New York, NY. She is 52 years old and has been practicing for 28 years. Dr. Anupama Goel, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Diane George, MD cares for children and adolescents undergoing stem cell transplantation as a treatment for cancer (particularly leukemia and lymphoma), noncancerous blood disorders (like sickle cell anemia), and immunodeficiencies. She specializes in transplantation for patients who don't have a related bone marrow donor, and also takes care of patients undergoing autologous stem cell transplantation for solid tumors. Dr. George was originally attracted to the field of pediatric oncology because she wanted to take on the challenge of fighting pediatric cancer, and stem cell transplantation offers the ultimate cure in select patients. It is a complex medical field, and Dr. George enjoys being able to take care of children with complex medical conditions. Dr. George also conducts clinical research. She is currently evaluating a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow. This approach reduces the risk of graft-versus-host disease (GVHD) - a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach benefits patients who do not have a well-matched family donor, and it could potentially make bone marrow transplantation an option for more patients. Dr. George is also interested in studying how a patient's immune system rebuilds itself after CD34-selected stem cell transplantation. At NewYork-Presbyterian/Morgan Stanley Children's Hospital, every member of a child's healthcare team shares the same compassion and dedication to helping them get well. Dr. George looks forward each day to the camaraderie, intellectual stimulation, and problem-solving she shares with fellow team members. After being in the field for more than 20 years, Dr. George uses the knowledge and experience she has gained to benefit patients and their families.

Biography: Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Ingham is Assistant Professor of Medicine in the Division of Hematology and Oncology at New York Presbyterian Hospital/Columbia University Medical Center. He received his medical degree from the University of Massachusetts Medical School and completed internship and residency training in Internal Medicine at New York University Medical Center, where he served as Chief Resident. He then completed fellowship training in Hematology and Medical Oncology at New York Presbyterian Hospital/Columbia University Medical Center where he served as Chief Fellow. Dr. Ingham specializes in the care of patients with sarcoma and gastrointestinal cancers and is also an active member of the experimental therapeutics unit. His research focuses on the development and clinical evaluation of new treatments for patients with sarcoma. He leads a National Cancer Institute (NCI) sponsored clinical trial evaluating a new treatment approach for uterine leiomyosarcoma based on research conducted at Columbia University. He also leads several other investigator-initiated clinical trials evaluating new targeted and immunotherapy based treatment approaches for leiomyosarcoma, liposarcoma and other types of sarcoma. He is the author of two recent authoritative reviews on the treatment of sarcoma published in the Journal of Clinical Oncology. He is the recipient of the 2019 Conquer Cancer Foundation of ASCO Career Development Award from the Sarcoma Foundation of America in recognition of his research and was also named a 2019 NextGen Innovator by HemOnc Today, among other awards and honors. His overall goal is to provide patients with compassionate oncologic care and access to the most promising treatment approaches.

Biography: Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic. During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center. Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom's macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Biography: My expertise is in pediatric hematology and oncology, with a particular focus on leukemias and lymphomas, or cancers of the blood, bone marrow, or lymph nodes. I am especially interested in chronic myeloid leukemia (CML). Because children are growing and developing, CML treatment and management present unique challengesthe same treatment options that work best for grown-ups may not be the right strategies for kids. I treat children, adolescents, and young adults. I love working with this population and developing long-lasting relationships with my young patients. I am especially passionate about delivering personalized care to each of thembecause no two kids are the same. Diseases like leukemia and lymphoma are challenging for anyone, but they can be especially hard on children. Symptoms like fatigue and joint pain can make it hard to move, play, and act like a kid, and some treatments can have severe side effects. I work to manage children's symptoms and choose the right treatments for their disease, based on their individual needs. Helping these children is the most satisfying goal I can imagine. My research revolves around the treatment of pediatric leukemias and lymphomas. I continue to explore the impact of current treatments, and I collaborate with basic science researchers to translate their breakthroughs into new drug development. I have also been involved in cancer survivorship research. As a professor and the section head of pediatric oncology, I am deeply committed to educating and mentoring medical students, residents, and fellows and helping to prepare the next generation of leaders in pediatric hematology/oncology.

Biography: Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis). Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Reshef trained in Hematology, Oncology and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program at Columbia, a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center.